Piramal Enterprises Demerger: What Is the Upside?
Moneylife Digital Team 09 October 2021
Piramal Enterprises Ltd (PEL) has announced the demerger of its pharmaceuticals business leading to creation of two independent listed firms focused on financial services and pharma. After the demerger, PEL will become a financial services company, while the pharma business will get consolidated under Piramal Pharma Ltd (PPL) and will be listed separately. PPL will issue four shares of Rs10...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback